Pfizer (PFE) Tops Q2 EPS by 12c, Raises FY Guidance
Get Alerts PFE Hot Sheet
Revenue Growth %: -23.7%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
(Updated - July 28, 2020 6:49 AM EDT)
Pfizer (NYSE: PFE) reported Q2 EPS of $0.78, $0.12 better than the analyst estimate of $0.66. Revenue for the quarter came in at $11.8 billion versus the consensus estimate of $11.55 billion.
GUIDANCE:
Pfizer sees 2020 EPS of $2.85-$2.95, versus the consensus of $2.88. Pfizer sees 2020 revenue of $48.6-50.6 billion, versus the consensus of $49.1 billion.
Based on results to date and these assumptions for the remainder of the year, Pfizer increased its 2020 financial guidance for Total Company(7) and New Pfizer(8) revenues and Adjusted diluted EPS(3) and reaffirmed all other financial guidance components. Total Company(7) financial guidance reflects a full year of revenue and expense contributions from Biopharma and Upjohn and is presented below.
|
| ||
Revenues | $48.6 to $50.6 billion | ||
(previously $48.5 to $50.5 billion) | |||
Adjusted Cost of Sales(3) as a Percentage of Revenues | 19.5% to 20.5% | ||
Adjusted SI&A Expenses(3) | $11.5 to $12.5 billion | ||
Adjusted R&D Expenses(3) | $8.6 to $9.0 billion | ||
Adjusted Other (Income)/Deductions(3) | Approximately $800 million of income | ||
Effective Tax Rate on Adjusted Income(3) | Approximately 15.0% | ||
Adjusted Diluted EPS(3) | $2.85 to $2.95 | ||
(previously $2.82 to $2.92) |
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Check Point Software Technology (CHKP) Tops Q1 EPS by 3c
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!